Drug profile · INN
meningococcal groups a, c, w-135 and y conjugate vaccine
NIMENRIX
meningococcal groups a, c, w-135 and y conjugate vaccine (NIMENRIX) is a immunostimulant.
EMA: approved Antiinfectives for systemic use (J07) J07AH08
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — meningococcal groups a, c, w-135 and y conjugate vaccine
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
meningococcal groups a, c, w-135 and y conjugate vaccine (NIMENRIX) is a immunostimulant.
Key facts
INN meningococcal groups a, c, w-135 and y conjugate vaccine
Brand NIMENRIX
Mechanism Immunostimulant
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AH08
Mechanism of action
Immunostimulant
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is meningococcal groups a, c, w-135 and y conjugate vaccine?
meningococcal groups a, c, w-135 and y conjugate vaccine (NIMENRIX) is a immunostimulant.
What is the brand name for meningococcal groups a, c, w-135 and y conjugate vaccine?
NIMENRIX is a marketed brand name for meningococcal groups a, c, w-135 and y conjugate vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.